A detailed history of Northwest Financial Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Northwest Financial Advisors holds 18 shares of LLY stock, worth $14,187. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18
Previous 193 90.67%
Holding current value
$14,187
Previous $175 Million 90.82%
% of portfolio
0.01%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $135,124 - $168,003
-175 Reduced 90.67%
18 $16.1 Million
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $4,349 - $5,454
6 Added 3.21%
193 $175 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $91,791 - $122,803
155 Added 484.38%
187 $146 Million
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $16,806 - $19,812
32 New
32 $18.7 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Northwest Financial Advisors Portfolio

Follow Northwest Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Financial Advisors with notifications on news.